|Publisher:||Random House Inc|
|Publish Date:||Aug 2005|
|Number of Pages:||319|
|Shipping Weight (in pounds):||1.0|
|Product in Inches (L x W x H):||5.35 x 0.76 x 7.91|
|Introduction : drugs are different|
|The $200 billion colossus|
|The creation of a new drug|
|How much does the pharmaceutical industry really spend on R & D?|
|Just how innovative is this industry?|
|Me-too" drugs - the main business of the pharmaceutical industry|
|How good are new drugs?|
|The hard sell ... lures, bribes, and kickbacks|
|Marketing masquerading as education|
|Marketing masquerading as research|
|Patent games - stretching out monopolies|
|Buying influence - how the industry makes sure it gets its way|
|Is the party over?|
|How to save the pharmaceutical industry - and get our money's worth|
With the recent controversy over Medicare reform for prescription drugs, there couldn't be a better time for a coherent book on the state of the pharmaceutical industry. Angell, the former editor in chief of the New England Journal of Medicine, offers an impassioned expos? of how money is really spent by this gigantic and immensely wealthy industry. Angell looks at the role of academia in drug research, how the FDA is impacted by the industry, and how pharmaceutical companies influence medical education and research.
She devotes a large part of her book to an analysis of recent U.S. legislation that, while well meaning, has actually been a tremendous financial boon to the pharmaceutical industry. Angell concludes with practical suggestions on how the industry and our governmental policies can be reformed to bring the profits of this necessary industry to a more reasonable level. Every registered voter should read this book; highly recommended for public libraries.
[See Prepub Alert, LJ 4/1/04.] - Tina Neville, Univ. of South Florida at St. Petersburg Lib.
(c). Copyright 2010. Library Journals LLC, a wholly owned subsidiary of Media Source, Inc. No redistribution permitted.
During her two decades at The New England Journal of Medicine, Dr. Marcia Angell had a front-row seat on the appalling spectacle of the pharmaceutical industry. She watched drug companies stray from their original mission of discovering and manufacturing useful drugs and instead become vast marketing machines with unprecedented control over their own fortunes. She saw them gain nearly limitless influence over medical research, education, and how doctors do their jobs. She sympathized as the American public, particularly the elderly, struggled and increasingly failed to meet spiraling prescription drug prices. Now, in this bold, hard-hitting new book, Dr. Angell exposes the shocking truth of what the pharmaceutical industry has become–and argues for essential, long-overdue change.
Currently Americans spend a staggering $200 billion each year on prescription drugs. As Dr. Angell powerfully demonstrates, claims that high drug prices are necessary to fund research and development are unfounded: The truth is that drug companies funnel the bulk of their resources into the marketing of products of dubious benefit. Meanwhile, as profits soar, the companies brazenly use their wealth and power to push their agenda through Congress, the FDA, and academic medical centers.
Zeroing in on hugely successful drugs like AZT (the first drug to treat HIV/AIDS), Taxol (the best-selling cancer drug in history), and the blockbuster allergy drug Claritin, Dr. Angell demonstrates exactly how new products are brought to market. Drug companies, she shows, routinely rely on publicly funded institutions for their basic research; they rig clinical trials to make their products look better than they are; and they use their legions of lawyers to stretch out government-granted exclusive marketing rights for years. They also flood the market with copycat drugs that cost a lot more than the drugs they mimic but are no more effective.
The American pharmaceutical industry needs to be saved, mainly from itself, and Dr. Angell proposes a program of vital reforms, which includes restoring impartiality to clinical research and severing the ties between drug companies and medical education. Written with fierce passion and substantiated with in-depth research, The Truth About the Drug Companies is a searing indictment of an industry that has spun out of control.
Save $25 when you open a Walmart® Credit Card and spend $75 today.*
*Offer subject to credit approval